Konieczny K, Detraux J, Bouckaert F
Alpha Psychiatry. 2024; 25(2):190-205.
PMID: 38798809
PMC: 11117426.
DOI: 10.5152/alphapsychiatry.2024.231460.
Cannilla H, Messe M, Girardin F, Borruat F, Bally J
Tremor Other Hyperkinet Mov (N Y). 2024; 14:23.
PMID: 38737300
PMC: 11086588.
DOI: 10.5334/tohm.832.
Orji G, Mansoor M, Bellegarde S, Punter L, Odenigbo N, Fouron P
Cureus. 2023; 15(5):e39361.
PMID: 37362457
PMC: 10285111.
DOI: 10.7759/cureus.39361.
Fenner R, Bookbinder S, Kratzer J, McNeal A
Cureus. 2022; 14(8):e28076.
PMID: 36127998
PMC: 9477549.
DOI: 10.7759/cureus.28076.
Rossi F, Rossi E, Hoffmann M, Liu W, Cruz R, Antonovich N
Cerebellum. 2017; 16(5-6):973-978.
PMID: 28593454
DOI: 10.1007/s12311-017-0868-3.
Drug Interactions with Lithium: An Update.
Finley P
Clin Pharmacokinet. 2016; 55(8):925-41.
PMID: 26936045
DOI: 10.1007/s40262-016-0370-y.
Impact of lithium alone or in combination with haloperidol on selected oxidative stress parameters in human plasma in vitro.
Gawlik-Kotelnicka O, Mielicki W, Rabe-Jablonska J, Strzelecki D
Redox Rep. 2015; 21(1):45-49.
PMID: 26193071
PMC: 6837648.
DOI: 10.1179/1351000215Y.0000000030.
Drug-induced cerebellar ataxia: a systematic review.
van Gaalen J, Kerstens F, Maas R, Harmark L, van de Warrenburg B
CNS Drugs. 2014; 28(12):1139-53.
PMID: 25391707
DOI: 10.1007/s40263-014-0200-4.
Neurotoxicity with combined use of lithium and haloperidol decanoate.
Colvard M, Gentry J, Mullis D
Prim Care Companion CNS Disord. 2014; 15(6).
PMID: 24800119
PMC: 3977768.
DOI: 10.4088/PCC.13l01563.
Treatment of the special patient with schizophrenia.
Conley R, Kelly D
Dialogues Clin Neurosci. 2011; 3(2):123-35.
PMID: 22034474
PMC: 3181645.
Increased risk of occurrence of neuroleptic malignant syndrome on combined treatment with lithium and neuroleptic.
Alexander P, Thomas R
Indian J Psychiatry. 2011; 39(3):251-5.
PMID: 21584083
PMC: 2967123.
Lithium toxicity - a descriptive study.
Kumar R, Deb J, SINHA B, Sinha V
Indian J Psychiatry. 2011; 43(1):52-7.
PMID: 21407839
PMC: 2955933.
Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.
Tuglu C, Erdogan E, Abay E
J Korean Med Sci. 2005; 20(4):691-4.
PMID: 16100469
PMC: 2782173.
DOI: 10.3346/jkms.2005.20.4.691.
[Neurotoxic encephalopathy caused by neuroleptics and lithium].
Lambreva E, Vecellio M, Wieser H, Buddeberg C
Nervenarzt. 2005; 76(6):756-9.
PMID: 15959751
DOI: 10.1007/s00115-004-1831-3.
Assessment and treatment of bipolar disorder in the elderly.
Eastham J, Jeste D, Young R
Drugs Aging. 1998; 12(3):205-24.
PMID: 9534021
DOI: 10.2165/00002512-199812030-00004.
Clinically significant interactions of psychotropic agents with antipsychotic drugs.
Meyer M, Baldessarini R, Goff D, Centorrino F
Drug Saf. 1996; 15(5):333-46.
PMID: 8941495
DOI: 10.2165/00002018-199615050-00004.
Prolonged neurological sequelae after combination treatment with lithium and antipsychotic drugs.
Mani J, Tandel S, Shah P, Karnad D
J Neurol Neurosurg Psychiatry. 1996; 60(3):350-1.
PMID: 8609524
PMC: 1073870.
DOI: 10.1136/jnnp.60.3.350.
Clinical relevance of drug interactions with lithium.
FINLEY P, Warner M, Peabody C
Clin Pharmacokinet. 1995; 29(3):172-91.
PMID: 8521679
DOI: 10.2165/00003088-199529030-00004.
Review of clinically important drug interactions with lithium.
Harvey N, Merriman S
Drug Saf. 1994; 10(6):455-63.
PMID: 7917074
DOI: 10.2165/00002018-199410060-00004.
Effect of chronic lithium treatment with or without haloperidol on number and sizes of neurons in rat neocortex.
Licht R, Larsen J, Smith D, Braendgaard H
Psychopharmacology (Berl). 1994; 115(3):371-4.
PMID: 7871078
DOI: 10.1007/BF02245079.
